California Public Employees Retirement System Unity Biotechnology, Inc. Transaction History

California Public Employees Retirement System

  • $147 Billion
  • Q4 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021
SELL
$4.15 - $6.3 $286,765 - $435,330
-69,100 Closed
0 $0
Q3 2020

Nov 05, 2020
BUY
$2.94 - $12.43 $7,350 - $31,075
2,500 Added 3.75%
69,100 $239,000
Q2 2020

Aug 12, 2020
BUY
$5.28 - $9.67 $194,040 - $355,372
36,750 Added 123.12%
66,600 $578,000
Q4 2019

Jan 27, 2020
BUY
$5.99 - $8.38 $82,063 - $114,806
13,700 Added 84.83%
29,850 $215,000
Q2 2019

Aug 15, 2019
BUY
$7.59 - $10.21 $122,578 - $164,891
16,150 New
16,150 $153,000

Others Institutions Holding UBX

# of Institutions
1
Shares Held
4.41M
Call Options Held
0
Put Options Held
0
View Full List

About Unity Biotechnology, Inc.

UBX Quotes by TradingView
  • Ticker UBX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 14,036,200
  • Market Cap $25.7M
  • Description
  • Unity Biotechnology, Inc., a biotechnology company, engages in the research and development of therapeutics to slow, halt, or reverse diseases of aging. The company's lead drug candidate includes UBX1325, which is Phase II clinical trial for the treatment of age-related diseases of the eye, including diabetic macular edema, age-related macular d...
More about UBX
Track This Portfolio

Track California Public Employees Retirement System Portfolio

Follow California Public Employees Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email